Zymeworks Inc. ·

ZYME 8-K 2026-06-29

Zymeworks Inc. (ZYME) 8-K dated 2026-06-29 — accession 0001193125-26-286829. This URL is the filing, not the ZYME hub.

Zymeworks Inc. (ZYME) is a biotechnology company listed on NASDAQ.

Zymeworks Inc. filed a 8-K on 2026-06-29. Accession 0001193125-26-286829.

Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.

Not investment advice. The ZYME SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR